0001213900-24-033831.txt : 20240417 0001213900-24-033831.hdr.sgml : 20240417 20240417163233 ACCESSION NUMBER: 0001213900-24-033831 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240415 FILED AS OF DATE: 20240417 DATE AS OF CHANGE: 20240417 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Jermasek Douglas CENTRAL INDEX KEY: 0001955273 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40582 FILM NUMBER: 24851542 MAIL ADDRESS: STREET 1: 4300 EL CAMINO REAL STREET 2: SUITE 210 CITY: LOS ALTOS STATE: CA ZIP: 94022 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Unicycive Therapeutics, Inc. CENTRAL INDEX KEY: 0001766140 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 813638692 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4300 EL CAMINO REAL, SUITE 210 CITY: LOS ALTOS STATE: CA ZIP: 94022 BUSINESS PHONE: 650-384-0642 MAIL ADDRESS: STREET 1: 4300 EL CAMINO REAL, SUITE 210 CITY: LOS ALTOS STATE: CA ZIP: 94022 4 1 ownership.xml X0508 4 2024-04-15 0 0001766140 Unicycive Therapeutics, Inc. UNCY 0001955273 Jermasek Douglas C/O UNICYCIVE THERAPEUTICS 4300 EL CAMINO REAL SUITE 210 LOS ALTOS CA 94022 0 1 0 0 EVP of Corporate Strategy 0 Stock Options 1.14 2024-04-15 4 A 0 463250 0 A 2034-04-15 Common Stock 463250 1973250 D 115,813 of the stock options vest on first anniversary of the date of grant and 1/36th of the remaining options vest at the end of each successive month thereafter. /s/ Doug Jermasek 2024-04-17